|
MAP2K1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.397330E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.336700E-03 |
| Normal-vs-Stage2 |
7.604300E-02 |
| Normal-vs-Stage3 |
2.085200E-01 |
| Normal-vs-Stage4 |
1.962960E-01 |
| Stage1-vs-Stage2 |
6.619600E-01 |
| Stage1-vs-Stage3 |
1.972810E-01 |
| Stage1-vs-Stage4 |
7.052400E-01 |
| Stage2-vs-Stage3 |
2.698200E-01 |
| Stage2-vs-Stage4 |
5.173400E-01 |
| Stage3-vs-Stage4 |
6.264600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.164000E-02 |
| Normal-vs-AfricanAmerican |
2.796100E-02 |
| Normal-vs-Asian |
4.942100E-02 |
| Caucasian-vs-AfricanAmerican |
3.598800E-01 |
| Caucasian-vs-Asian |
1.849770E-01 |
| AfricanAmerican-vs-Asian |
4.171400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.833900E-02 |
| Normal-vs-Female |
1.924510E-03 |
| Male-vs-Female |
2.298600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.202390E-02 |
| Normal-vs-Age(41-60Yrs) |
2.795500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.244400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.573900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.285800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.040800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.471600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.885650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.739000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.447700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.089800E-01 |
| Classical-VS-Follicular |
7.245600E-01 |
| Classical-VS-Other |
2.775400E-01 |
| Classical-VS-Normal |
8.216100E-04 |
| Tall-VS-Follicular |
3.750600E-01 |
| Tall-VS-Other |
2.567200E-01 |
| Tall-VS-Normal |
2.120200E-01 |
| Follicular-VS-Other |
1.212020E-01 |
| Follicular-VS-Normal |
8.478100E-02 |
| Other-VS-Normal |
4.709400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.617500E-02 |
| Normal-vs-N1 |
3.045200E-01 |
| N0-vs-N1 |
8.369600E-01 |
|
|
